Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The day DCVax-L is approved in UK , the next trade day will be unbelievable . The other RA will not be far behind and the frenzy to have shares will be on.
Shorts and liars care nothing about facts.
The shorts played chess against a Grand Master’s strategy and they made amateur moves and wrong assumptions.
Northwest bio , with the most significant gbm therapy in the history of glioblastoma, DCVax-L ,has to be in talks with one that chooses to own the cancer therapy market. Any who aren’t in talks with them, have chosen to be also rans.
I am amazed that any one of the conference large pharma attendees could attend the conference and not be in a meeting discussing terms of buyout or partnership.
Another excellent reaction and request by an informed professional, in contrast to Stat uninformed and unprofessional statements.
Dr Liau may be covered by UCLA law department.
excerpt from that Forbes article
This is particularly true for diseases where there are no other alternatives and where there is a dire need of treatment. Such was the case with Chen’s example of Sarepta’s Duchenne muscular dystrophy drug, Exondys 51, a drug that was approved by Dr. Janet Woodcock (head of the FDA’s Center of Drug Evaluation and Research), over the objections of FDA senior reviewers. But this had little to do with industry financial support of the FDA. The very public nature of this debate teaches more about the challenges in approving new drugs as opposed to being an example of FDA pro-industry bias.
The FDA chief said in an interview, they favor big pharmaceutical companies because they pay and small don’t.
Every day I expect to awaken to approval from UK MHRA & then we will see what else takes place.
Thank you
“speaking with malicious intent.” quote
Most likely and very likely many here.
I like that thought of simultaneously destroying shorts and making us all very content with a global DCVax-L approval.
quote “If Citadel has hundreds of millions in naked shorts in Northwest, they're finished too!!! “
Not enough could be done to anyone who uses naked short (Fraud ) and therefore theft of shares. A complete loss of all personal assets of every person involved and complete forfeiture of all assets of company . Life in prison for everyone involved , including any person proven to have any knowledge no matter how little of the crime and didn’t report it to every authority available to prosecute.
Thank you for your update. I can see why the discussion settled you.
With all the data to date, plus the unreleased data, it doesn’t take but a couple days at most to look at data, listen to experts and come to the conclusion this needs to be approved ASAP. The thought that this should be looked at for months , is ridiculous. It is an open and shut case. Maybe they should have 2 or 3 of the most noted physicians in the world come to their office with a box of crayons and illustrate the enormous benefits clearly outlined in the data in front of them . They can use little words to help the RAs understand better.
APPROVED
This is the new SOC for GBM .
Why is there a lack of motivation for a followup article to point out the attacks or favoritism in place right now hindering or helping both small and large pharma ?
I would love more truths to shut down these pathetic attacks on new SOC
MHRA approval of DCVax-L is coming faster than any of you think.
You are way more than an errand boy. Your summary and opinions are very valuable . I thank you for every thing you do.
This was a point
Industry Expert Theater sessions are not official presentations of the 2022 ASCO Annual Meeting and are not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or Conquer Cancer the ASCO Foundation. These sessions are not CME-accredited.
This schedule is subject to change. The information listed is current as of April 5, 2022.
Just hoping for a one time honest effort from them.
There would be no reason to keep them from contacting LE and demanding an investigation at all levels.
They should contact law enforcement and FBI
Share price still $6 below where it should be
Outcome Measures
Go to sections
Primary Outcome Measures :
The primary objective of this study is to compare overall survival (OS) between patients randomized to DCVax-L and control patients from comparable, contemporaneous trials who received standard of care therapy only, in newly diagnosed glioblastoma. [ Time Frame: Until death ]
Secondary Outcome Measures :
The first secondary objective is to compare overall survival (OS) between patients randomized to placebo who received DCVax-L treatment following disease recurrence, and control patients from comparable, contemporaneous clinical trials, in recurrent GBM. [ Time Frame: Until death ]
Fomenting anxiety, fear and discontent is all some know how to do, having never accomplished anything as great as bringing dcvax through clinical, in their lives.
It would be interesting to know if Dr Brem has followed any of the current dcvax revelations showing its continued and enhanced effectiveness .
These guys give ammunition to the shorts everyday.
Most certainly the BOD, LP and DI have a different timeline and agenda than people here. However, there are 1000s of shareholders not represented on these boards and not selling.
Dr Mulholland was about as flat and lifeless as any presenter I’ve ever seen. He had only seen the presentation the day he was asked to present. They had negative points at the beginning of the presentation , which were put to rest only after 8 minutes and that didn’t help.
Yes, he always loses . splat or boom
We need the Roadrunner. beep beep
Excellent
An orchestrated forced share price drop has nothing to do with the company’s health. If I push someone down the stairs , it is because of my actions ,not theirs.
The UK deserve all the credit for promoting and helping get DCVax-L to patients. Mose certainly their Special Program of which they chose DCVax to be first.
The FDA has routinely been a roadblock to advancing good medicine to the citizens of the US. The FDA apparently works for those who pay its bills and that is the large pharmaceutical companies.
They obviously disregarded their mission statement by failing to look at facts.
Chemo has a couple side effects
Fatigue
? Hair loss
? Easy bruising and bleeding
? Infection
? Anemia (low red blood cell counts)
? Nausea and vomiting
? Appetite changes
? Constipation
? Diarrhea
? Mouth, tongue, and throat problems such as sores and pain with swallowing
? Peripheral neuropathy or other nerve problems, such as numbness, tingling, and
pain
? Skin and nail changes such as dry skin and color change
? Urine and bladder changes and kidney problems
? Weight changes
? Chemo brain, which can affect concentration and focus
? Mood changes
? Changes in libido and sexual function
? Fertility problems
Great advice.